Absolute Preoperative C-Reactive Protein Predicts Metastasis and Mortality in the First Year Following Potentially Curative Nephrectomy for Clear Cell Renal Cell Carcinoma
Authors:
- 1 February 2010
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 183 (2) , 480-485
Abstract
C-reactive protein is an inflammatory biomarker associated with tumor burden and metastasis in renal cell carcinoma. Recent studies suggest that preoperative C-reactive protein predicts metastasis and mortality after nephrectomy for localized renal cell carcinoma. However, these studies dichotomized C-reactive protein (typically 10 mg/l or greater vs less than 10 mg/l). Considering the continuous range of C-reactive protein (less than 1 mg/l to greater than 100 mg/l) we assessed the ability of absolute preoperative C-reactive protein to predict metastases and mortality as a continuous variable. Patients with clinically localized (T1-T3N0M0) clear cell renal cell carcinoma were followed for 1 year postoperatively. Metastases were identified radiologically and mortality was determined by death certificate. Univariate and multivariate binary logistic regression analyses examined 1-year relapse-free survival and overall relative survival across patient and disease characteristics. Of the 130 patients in this study metastases developed in 24.6% and 10.8% of the patients died. Mean (SD) preoperative C-reactive protein for patients in whom metastases did and did not develop was 89.17 (74.17) and 9.16 (30.62) mg/l, respectively. Mean preoperative C-reactive protein for patients who did and did not die was 102.61 (77.32) and 19.52 (46.10) mg/l, respectively. On multivariate analysis SSIGN score (p <0.001) and preoperative C-reactive protein (B 0.027, SE 0.003, p <0.001) were significant predictors of relapse-free survival, and preoperative platelets (p = 0.009) and preoperative C-reactive protein (B 0.011, SE 0.008, p <0.001) were significant predictors of overall relative survival. Absolute preoperative C-reactive protein is a robust predictor of metastasis and mortality after nephrectomy for localized renal cell carcinoma. Clinicians should consider absolute preoperative C-reactive protein to identify high risk patients for closer surveillance or additional therapy. In addition, predictive algorithms and models of metastasis should consider incorporating C-reactive protein as a continuous variable to maximize predictive ability.Keywords
This publication has 20 references indexed in Scilit:
- Development and External Validation of a New Outcome Prediction Model for Patients With Clear Cell Renal Cell Carcinoma Treated With Nephrectomy Based on Preoperative Serum C-Reactive Protein and TNM Classification: The TNM-C ScoreJournal of Urology, 2009
- Surveillance for renal cell carcinoma: Why and how? When and how often?Urologic Oncology: Seminars and Original Investigations, 2008
- The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancerBJU International, 2008
- Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse‐free and cancer‐specific survival in patients undergoing potentially curative resection for renal cancerBJU International, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Prognostic markers in renal cell carcinomaCurrent Opinion in Urology, 2007
- C‐reactive protein is an informative predictor of renal cell carcinoma‐specific mortalityCancer, 2007
- Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissueKidney International, 2005
- Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- Resection of metastatic renal cell carcinoma.Journal of Clinical Oncology, 1998